Abstract
Patients with generalized anxiety disorder (n = 18) entered a 21-day, double-blind, placebo-controlled random assignment trial of clorazepate. Positron emission tomography with 18F-deoxyglucose was carried out before and after treatment. Decreases in glucose metabolic rate in visual cortex and relative increases in the basal ganglia and thalamus were found. A correlation between regional changes in metabolic rate and regional benzodiazepine receptor binding density from other human autopsy studies was observed; brain regions highest in receptor density showed the greatest decrease in rate.
Original language | English |
---|---|
Pages (from-to) | 2393-2400 |
Number of pages | 8 |
Journal | Life Sciences |
Volume | 40 |
Issue number | 25 |
DOIs | |
State | Published - 22 Jun 1987 |
Externally published | Yes |